Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Leukemia. 2018 Feb 23;32(6):1370–1379. doi: 10.1038/s41375-018-0039-7

Table 6.

Prognostic impact of morphologic and minimal residual disease assessment of end of Induction bone marrow upon 5-year event free survival among patients with B-ALL

Univariate Multivariable
HR (95thCI) P value HR (95thCI) P value
Morphologic assessment
  M1 Ref <0.0001 Ref 0.05
  M2 2.7 (1.9–3.8) 1.5 (1.0–2.2)
MRD, per log percent 1.3 (1.2–1.4) <0.0001 1.3 (1.2–1.4) <0.0001

ALL – acute lymphoblastic leukemia; CI – confidence interval; HR – hazards ratio; MRD – minimal residual disease